79 research outputs found
DNA looping by FokI: the impact of twisting and bending rigidity on protein-induced looping dynamics
Protein-induced DNA looping is crucial for many genetic processes such as transcription, gene regulation and DNA replication. Here, we use tethered-particle motion to examine the impact of DNA bending and twisting rigidity on loop capture and release, using the restriction endonuclease FokI as a test system. To cleave DNA efficiently, FokI bridges two copies of an asymmetric sequence, invariably aligning the sites in parallel. On account of the fixed alignment, the topology of the DNA loop is set by the orientation of the sites along the DNA. We show that both the separation of the FokI sites and their orientation, altering, respectively, the twisting and the bending of the DNA needed to juxtapose the sites, have profound effects on the dynamics of the looping interaction. Surprisingly, the presence of a nick within the loop does not affect the observed rigidity of the DNA. In contrast, the introduction of a 4-nt gap fully relaxes all of the torque present in the system but does not necessarily enhance loop stability. FokI therefore employs torque to stabilise its DNA-looping interaction by acting as a ‘torsional’ catch bond
UV absorption and Raman spectra of the ground states and time-resolved resonance Raman spectra of the lowest excited triplet states of the E and Z isomers of 2,5-dimethyl-1,3,5-hexatriene. Indication of nonequilibration of excited rotamers in the lowest triplet state
Patterns of Recurrence and Survival After Pelvic Treatment for Locally Advanced Penile Cancer
BACKGROUND: Penile cancer (PeCa) is rare, and the survival of patients with advanced disease remains poor. A better understanding of where treatment fails could aid the development of new treatment strategies. OBJECTIVE: To describe the disease course after pelvic lymph node (LN) treatment for PeCa. DESIGN, SETTING, AND PARTICIPANTS: We retrospectively analysed 228 patients who underwent pelvic LN treatment with curative intent from 1969 to 2016. The main treatment modalities were neoadjuvant chemotherapy, chemoradiation, and pelvic LN dissection. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: In the case of multiple recurrence locations, the most distant location was taken and recorded as follows: local (penis), regional (inguinal and pelvic LN), and distant (any other location). A competing risk analysis was used to calculate the time to recurrence per location, and a Kaplan-Meier analysis was used for overall survival (OS). RESULTS AND LIMITATIONS: The median follow-up of the surviving patients was 79 mo. The reason for pelvic treatment was pelvic involvement on imaging (29%), two or more tumour-positive inguinal LNs (61%), or inguinal extranodal extension (52%). More than half of the patients (61%) developed a recurrence. The median recurrence-free survival was 11 mo. The distribution was local in 9%, regional in 27%, and distant in 64% of patients. The infield control rate of nonsystemically treated patients was 61% (113/184). From the start of pelvic treatment, the median OS was 17 mo (95% confidence interval 12–22). After regional or distant recurrence, all but one patient died of PeCa with median OS after a recurrence of 4.4 (regional) and 3.1 (distant) mo. This study is limited by its retrospective nature. CONCLUSIONS: The prognosis of PeCa patients treated on their pelvis who recur despite locoregional treatment is poor. The tendency for systemic spread emphasises the need for more effective systemic treatment strategies. PATIENT SUMMARY: In this report, we looked at the outcomes of penile cancer patients in an expert centre undergoing various treatments on their pelvis. We found that survival is poor after recurrence despite locoregional treatment. Therefore, better systemic treatments are necessary
Complete remission of coronary vasculitis in Churg–Strauss Syndrome by prednisone and cyclophosphamide
Soluble HLA in the aqueous humour of uveal melanoma is associated with unfavourable tumour characteristics
A high HLA expression in uveal melanoma (UM) is part of the prognostically unfavorable inflammatory phenotype. We wondered whether the presence of soluble HLA (sHLA) in the aqueous humour is associated with clinical, histopathological or genetic tumour characteristics, and represents tumour HLA expression and intratumoural inflammation. Aqueous humour from 108 UM patients was analysed for the presence of sHLA, using a Luminex assay specific for HLA Class I. Clinical and genetic parameters were compared between sHLA-positive and negative eyes. A qPCR analysis was performed on tumour tissue using a Fluidigm assay. In 19/108 UM-containing eyes, the sHLA level in the aqueous was above the detection limit. Tumours in sHLA-positive eyes were significantly larger, more frequently involved the ciliary body, and more often showed monosomy 3, gain of chromosome 8q and loss of BAP1 staining. Melanoma-related survival was worse in patients with sHLA-positive aqueous humour. sHLA in the aqueous did not represent the tumour's HLA expression and did not relate to immune cell infiltration in the tumour. We conclude that UM-containing eyes may contain sHLA in the aqueous humour, where it is a prognostically-unfavourable sign and may influence local immune responses
Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study
Data on the impact of long term treatment with immunomodulatory
drugs (IMiD) on health-related quality of life (HRQoL) is limited.
The HOVON-87/NMSG18 study was a randomized, phase 3 study
in newly diagnosed transplant ineligible patients with multiple myeloma,
comparing melphalan-prednisolone in combination with thalidomide or
lenalidomide, followed by maintenance therapy until progression (MPT-T
or MPR-R). The EORTC QLQ-C30 and MY20 questionnaires were completed at baseline, after three and nine induction cycles and six and 12
months of maintenance therapy. Linear mixed models and minimal important differences were used for evaluation. 596 patients participated in
HRQoL reporting. Patients reported clinically relevant improvement in global quality of life (QoL), future perspective and role and emotional functioning, and less fatigue and pain
in both arms. The latter being of large effect size
So Close, yet so Far: Discrepancies between Uveal and Other Melanomas. A Position Paper from UM Cure 2020
Multicenter, International Assessment of the Eighth Edition of the American Joint Committee on Cancer Cancer Staging Manual for Conjunctival Melanoma
Cuadernos de pedagogía
Resumen tomado de la publicación.En los últimos años, tanto en los centros escolares como en las universidades, los profesores-mentores están acaparando mayor protagonismo en el proceso formativo de profesores noveles. El éxito de esta función profesional depende, entre otros elementos, de la calidad del diálogo entre ambas partes. Para que éste resulte eficaz es fundamental que en los contextos de la práctica exista una correspondencia entre el enfoque adoptado por el mentor y las características y las necesidades del profesor en formación. Lograr este propósito no es fácil: muchas veces el Factor de Correspondencia, también llamado Match Factor o factor M, no existe. Esta circunstancia puede obstaculizar o ralentizar innecesariamente el proceso formativo del profesor en formación a la vez que amenaza con incidir de forma negativa en la motivación y las ganas de trabajar entre ambos interlocutores. Las partes implicadas suelen experimentar dificultades para reconocer y verbalizar los problemas que surgen de la experiencia docente. Se toma como punto de partida el modelo MERID (MEntor Roles In Dialogues), centrado en los roles que puede desempeñar el mentor en el diálogo con el profesor novel, con el fin de presentar un ejercicio de reflexión que permita entender y hacer un seguimiento del factor M.Biblioteca de Educación del Ministerio de Educación, Cultura y Deporte; Calle San Agustín, 5 - 3 planta; 28014 Madrid; Tel. +34917748000; [email protected]
- …